Ecigs and therapeutic claim, what is the risk and where do we go?

Over 6 months (January – June 2015) advertising by 23 leading e-cigarette brands through social media channels and blogs as well as user-generated content (testimonials) appearing within brand-sponsored Web sites were analyzed by Stanford researchers. They isolated an explicit claim of cessation efficacy with unambiguous statements in favor of smoking cessation success. They also point out implicit claims that use euphemisms such … Continue reading Ecigs and therapeutic claim, what is the risk and where do we go?